Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
INSM
INSM News & Events
-
Add to Watchlist
Trade INSM
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
INSM News
Insmed Halts Lung Disorder Therapy R&D Program After Trial Failure
Apr 08 2026
seekingalpha
Insmed Halts Brinsupri Development for HS After Trial Failure
Apr 08 2026
Yahoo Finance
Insmed Discontinues Brensocatib Development After Phase 2b Study Fails
Apr 08 2026
NASDAQ.COM
Insmed Discontinues Brensocatib HS Program After Phase 2b Study Fails
Apr 07 2026
PRnewswire
Insmed's Investigational Treatment for Skin Disease Falls Short in Clinical Trial
Apr 07 2026
stocktwits
INSMED INC - PHASE 2B CEDAR STUDY OF BRENSOCATIB FAILED TO ACHIEVE EFFICACY GOALS
Apr 07 2026
moomoo
INSMED INC REPORTS NO NEW SAFETY CONCERNS FOR BRENSOCATIB IN PHASE 2B CEDAR TRIAL
Apr 07 2026
moomoo
Insmed, First Solar, and Aptiv Form Death Cross, Signaling Bearish Trends
Apr 06 2026
stocktwits
Show More News
INSM Events
No data
INSM Monitor News
Insmed shares rise 5.5% on positive competitive data
Mar 31 2026
Insmed stock rises after Morgan Stanley upgrade to overweight
Mar 30 2026
Insmed Reports Positive Phase 3b ENCORE Study Results for ARIKAYCE
Mar 25 2026
Insmed Reports Positive Phase 3b ENCORE Study Results for ARIKAYCE
Mar 23 2026
Insmed Inc hits 5-day low amid market decline
Mar 20 2026
Insmed grants inducement awards to new employees
Mar 05 2026
Insmed Reports Strong 2025 Results and 2026 Revenue Guidance
Feb 25 2026
Insmed anticipates over $1 billion in BRINSUPRI revenue for 2026
Feb 20 2026
Show More Monitor News
INSM Earnings Analysis
Insmed Inc Q2 2025 Earnings: Growth Amidst Innovation- Intellectia AI™
8 months ago
Insmed Inc 2024 Earnings: Strong Growth Driven by ARIKAYCE- Intellectia AI™
1 years ago
People Also Watch
